News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Antonio Giordano: Cycling through Innovation at ESMO Asia 24
Antonio Giordano/X
Dec 9, 2024, 03:24

Antonio Giordano: Cycling through Innovation at ESMO Asia 24

Antonio Giordano, Breast Medical Oncologist at Harvard Medical School, shared a post on X:

“New way to target cell cycle. Cycling through Innovation ESMO – Eur. Oncology ESMOASIA24 with Drs. Lee and Naito.

Exciting new drugs to target CDK4, CDK2, and more in HR+/Her2- MBC.

Taking 2L PFS closer to 12 months and away from chemo.”

Antonio Giordano: Cycling through Innovation at ESMO Asia 24

Antonio Giordano cancer ESMO - Eur. Oncology ESMO - Eur. Oncology ESMOASIA24 ESMOASIA24 fight against cancer Global fight against cancer Harvard Medical School Lee MedOnc Naito OncoDaily Oncology
Special Coverage
Blog
Jan 9, 2025, 17:18
Fumiko Ladd Chino: 2025  ASCO JCO Journals Editorial Fellow Application is OPEN
Insight
Jan 9, 2025, 17:18
Jessica MacIntyre: Excited for this year’s 50th Annual Oncology Nursing Society Congress
Blog
Jan 9, 2025, 17:04
Mehdi Hamadani: Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide
Blog
Jan 9, 2025, 16:48
Design of a Fc-engineered tetravalent bispecific antibody targeting PD-1 and VEGF with cooperative biological effects
Blog
Jan 9, 2025, 16:41
Elisabetta Munzone: Harmonizing EHRs in Italy for Better Healthcare Outcomes and Cost Reduction
Blog
Jan 9, 2025, 16:38
Trastuzumab deruxtecan in HER2-positive and HER2-low breast cancer patients with leptomeningeal carcinomatosis
Blog
Jan 9, 2025, 16:35
Ahmed Kotb: Ph-like ALL Signaling Pathways and Targets
Blog
Jan 9, 2025, 16:32
Priorities of ESTRO for engagement within the EURAMED framework
Blog
Jan 9, 2025, 16:29
Aakash Desai: Rybrevant + Lazcluze to show clinically meaningful improvement in OS vs osimertinib
Blog
Jan 9, 2025, 16:22
Isabel Preeshagul: Survey on addressing barriers to clinical trial accrual in patients with lung cancer
Blog
Jan 9, 2025, 16:20
Saddened to learn of the unexpected passing of Prof. Petra Feyer - MASCC
Blog
Jan 9, 2025, 16:07
Eric Racine: The Patient Advocacy Voices Podcast is Back for 2025